pubmed-article:18458693 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18458693 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
pubmed-article:18458693 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:18458693 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
pubmed-article:18458693 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:18458693 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18458693 | pubmed:dateCreated | 2008-5-6 | lld:pubmed |
pubmed-article:18458693 | pubmed:abstractText | To generate and characterize the anti-anti-idiotypic monoclonal antibody (MAb) of epithelial ovarian carcinoma (EOC)ìwith the aim of further investigating the mechanism of active immunotherapy of tumor vaccine. | lld:pubmed |
pubmed-article:18458693 | pubmed:language | chi | lld:pubmed |
pubmed-article:18458693 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18458693 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18458693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18458693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18458693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18458693 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18458693 | pubmed:month | Apr | lld:pubmed |
pubmed-article:18458693 | pubmed:issn | 1671-167X | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:HoltL BLB | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:ZhangChaoC | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:FengJieJ | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:YeXueX | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:LiXiao pingX | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:FuTian yunT | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:ChangXiao... | lld:pubmed |
pubmed-article:18458693 | pubmed:author | pubmed-author:WeiLi HuiLH | lld:pubmed |
pubmed-article:18458693 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18458693 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:18458693 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18458693 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18458693 | pubmed:pagination | 170-3 | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:meshHeading | pubmed-meshheading:18458693... | lld:pubmed |
pubmed-article:18458693 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18458693 | pubmed:articleTitle | [Preparation and characterization of monoclonal anti-anti-idiotypic antibody (3D12) of epithelial ovarian carcinoma]. | lld:pubmed |
pubmed-article:18458693 | pubmed:affiliation | Gynecological Oncology Centre, Peking University People's Hospital, Beijing 100044, China. | lld:pubmed |
pubmed-article:18458693 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18458693 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:18458693 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |